New heart mapping tech tested in ablation study
NCT ID NCT07210151
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 32 times
Summary
This study is testing a new 3D imaging system called VERAFEYE that helps doctors guide catheter ablation procedures for people with atrial fibrillation or atrial flutter. About 50 adults scheduled for ablation will take part. The goal is to see how well the system works and gather information to improve it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Na Homolce Hospital
RECRUITINGPrague, 150 30, Czechia
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.